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Background: The organization of higher order chromatin is an emerging epigenetic mechanism for understanding
development and disease. We and others have previously observed dynamic changes during differentiation and
oncogenesis in large heterochromatin domains such as Large Organized Chromatin K (lysine) modifications (LOCKs),
of histone H3 lysine-9 dimethylation (H3K9me2) or other repressive histone posttranslational modifications. The
microstructure of these regions has not previously been explored.
Results: We analyzed the genome-wide distribution of H3K9me2 in two human pluripotent stem cell lines and
three differentiated cells lines. We identified > 2,500 small regions with very low H3K9me2 signals in the body of
LOCKs, which were termed as euchromatin islands (EIs). EIs are 6.5-fold enriched for DNase I Hypersensitive Sites
and 8-fold enriched for the binding of CTCF, the major organizer of higher-order chromatin. Furthermore, EIs are
2–6 fold enriched for differentially DNA-methylated regions associated with tissue types (T-DMRs), reprogramming
(R-DMRs) and cancer (C-DMRs). Gene ontology (GO) analysis suggests that EI-associated genes are functionally
related to organ system development, cell adhesion and cell differentiation.
Conclusions: We identify the existence of EIs as a finer layer of epigenomic architecture within large
heterochromatin domains. Their enrichment for CTCF sites and DNAse hypersensitive sites, as well as association
with DMRs, suggest that EIs play an important role in normal epigenomic architecture and its disruption in disease.
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Epigenetics involves information retained during cell
division other than DNA sequence per se, and both
DNA methylation and post-translational modifications
of histones are fundamental in understanding normal
development and disease [1-3]. Genome-scale localization
of histone modifications had been extensively mapped in
mammalian genomes [4-10]. While most of these studies
focused on local regulatory elements such as promoters
and enhancers, global organization of the chromatin has
not been well understood.* Correspondence: afeinberg@jhu.edu
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reproduction in any medium, provided the orRecent evidence indicates that repressive histone mod-
ifications form large scale domains in both mouse and
human genomes. We had previously identified large
blocks of H3 lysine 9 dimethylation (H3K9me2), termed
Large Organized Chromatin K9-modifications (LOCKs),
which affect more than 40% of the mouse genome in
liver cells [11]. LOCKs significantly overlap with lamina-
associated domains (LADs) [12] and are associated with
domain-wide gene silencing in a tissue-specific manner.
Importantly, both coverage and domain size of LOCKs
increase upon differentiation of mouse embryonic stem
cells (ESCs) [11]. On the other hand, genome-scale reduc-
tion of LOCKs was seen in epithelial-to-mesenchymal
transition (EMT) induced by TGF-β treatment of mouse
hepatocytes, a process in which cells gain stem cell-like
and malignant-type traits [13]. Similarly, large blocks of
other repressive marks (H3K9me3 and H3K27me3) are
also found to expand in human lung fibroblasts comparedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in breast cancer cells relative to normal epithelial cells
[15]. Furthermore, large H3K9me3 and H4K20me3
blocks specifically coat olfactory receptor (OR) gene clus-
ters in mouse olfactory epithelium but not in liver [16].
Taken together, these data demonstrate that large hetero-
chromatin domains are highly dynamic in differentiation
and tumorigenesis.
DNA methylation has been tightly linked to develop-
ment and disease [1]. We previously reported that differ-
entially methylated regions (DMRs) related to tissue
specificity (T-DMRs), colon cancer (C-DMRs) and re-
programming (R-DMRs) have largely common targets in
the genome and are strongly associated with local regu-
lation of adjacent genes [17,18]. Whole genome bisulfite
sequencing had found partial methylated domains
(PMDs) which are highly methylated in human ESCs but
partially methylated in fibroblasts [19]. Similar large
hypomethylation blocks relative to normal cells have
been identified in colon cancer [20] and breast cancer
cells [15], and loss of methylation in these regions is ac-
companied by acquisition of large domains of H3K9me3
and H3K27me3 [15].
Surprisingly, the relationship of H3K9me2 LOCKs/
blocks to DMRs has not been previously assessed. In the
course of this investigation, we identified a new chroma-
tin unit we term “euchromatin island” which may serve
as a fulcrum between DNA methylation and chromatin
in development.
Results
We analyzed whole genome distribution of H3K9me2 by
ChIP-chip using a highly specific monoclonal antibody
in two human pluripotent stem cell (PSC) lines (human
ESC H1, human iPSC ADA-38) and three primary differ-
entiated cell lines: human astrocytes (HA), human aortic
endothelial cells (HAEC) and human pulmonary fibro-
blasts (HPF). For differentiated cells, we used early pas-
sages of primary cells instead of immortalized cell lines
to avoid potentially aberrant epigenetic changes due to
long time cell culture and immortalization of the cells
[21]. These differentiated lines represent three germ
layers: ectoderm (HA), mesoderm (HAEC) and endo-
derm (HPF).
We normalized the ChIP-chip data as described [11]
to calculate the log2 ratios of ChIP/Input comparable
among cell types. By using the 90th quantile as a cutoff
to define large domains, the genome coverage of LOCKs
was found to increase from 17.5-24% in PSC lines, to
39.3-44.8% in differentiated cells, and the average sizes
of LOCK expanded from 142–171 kb in PSC lines, to
233–315 kb in the differentiated. The trends were the
same when we used different cutoffs to define LOCKs
(Additional file 1: Table S1), consistent with our previousfindings that LOCKs increase after mouse ESC differen-
tiation [11]. For example, in the WSCD2 gene locus, only
some small H3K9me2 peaks can be seen in the PSCs,
but the H3K9me2 enriched regions expanded to ~350 kb
long and cover the whole gene body and its flanking
regions in the differentiated cells (Figure 1A).
To validate the ChIP-chip data, we performed quanti-
tative PCR (qPCR) on 23 loci using independently pre-
pared ChIP and input DNA samples from four cell
types. For all the cases, the quantitative differences of
H3K9me2 enrichments within and among samples
detected by ChIP-chip were well validated by qPCR
(Additional file 2: Figure S1). Overall, the ChIP/Input
log2 ratios of microarray (ChIP-chip) and qPCR were
strongly correlated (R2 = 0.87, Figure 1B), indicating that
the ChIP-chip data are of high quality.
To reveal the relationship between dynamics of
H3K9me2 and DNA methylation on a large scale, we
compared genome-wide distributions of LOCKs (this
study), PMDs in fibroblasts [14], and DNA hypomethy-
lation blocks in colon cancer [20]. LOCKs in fibro-
blasts (HPF) largely overlap PMDs (Additional file 3:
Figure S2A), and overall 61.5% regions of LOCKs in
HPF coincide with PMDs (p < 0.001, based on 1,000
permutations), and H3K9me2 signals in the regions of
PMDs are higher than non-PMD regions (Additional
file 3: Figure S2B). Furthermore, more than 80% LOCK
regions in HPF were contained within DNA hypomethy-
lation blocks found in colon cancer tissues (Additional
file 3: Figure S2). Thus, our data support a strong cor-
relation between LOCKs and DNA hypomethylation
blocks in human cells.
On closer examination of the microstructure of the
LOCKs, we noticed that many small H3K9me2-depleted
regions are located in the body of LOCKs. These regions
are a few kb in length, and away from the LOCK bound-
aries. We found that these regions are abundant in the
genome, and they appear to be associated with open
chromatin (see below). Thus, we termed these regions
Euchromatin Islands (EIs). As an example, an EI was
found near the transcription start sites (TSSs) of the
cadherin 11 gene (CDH11, Figure 2A), of which epigen-
etic disruption was associated with metastasis of human
cancers [22]. Other examples of EIs include within the
gene body of PDILT, a testis-specific gene; and down-
stream of the glycoprotein 2 (GP2) gene (Figure 2B).
Then we developed a statistical algorithm to identify
EIs genome-wide (see Methods). We identified 758 to
2,465 EIs across cell types, with average sizes from 4.4
to 5.9 kb (Table 1 and Additional file 4: Table S2).
These EIs form strong dips relative to adjacent LOCK
regions as demonstrated by average H3K9me2 densities
(Additional file 5: Figure S3). We have performed repli-




























































Figure 1 Global pattern of H3K9me2 in human pluripotent and differentiated cells. A) A representative region that shows LOCKs in
differentiated cells (HA, HAEC and HPF) but not PSCs (H1 and ADA-38). Shown are H3K9me2 signals of ChIP-chip experiments in a ~500 kb long
region containing WSCD2 gene. Positive and negative log2 (ChIP/Input) rations are shown in blue and red, respectively. B) qPCR validation of
ChIP-chip data. By comparing four cell lines in 23 regions (Figure S1), enrichments (log2 ChIP/Input) measured by ChIP-chip (Y axis) and ChIP-
qPCR (X axis) are highly correlated (R2 = 0.87).
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genome. The EIs detected from the replicate experi-
ments have high concordance with the ones from whole
genome arrays (Additional file 6: Figure S4). Percentage
of EIs detected from whole genome arrays that can also
be detected from replicate arrays are 76.3% for H1,
74.1% for ADA-38, 63.3% for HA, 84.4% for HAEC and
71.4% for HPF. To exclude the possibility that EIs
resulted from lack of histones in these regions, weplotted nucleosome density around EIs, and no deple-
tion of nucleosomes was observed in EIs (Additional
file 7: Figure S5), indicating that the observation of EIs
is not due to nucleosome positioning.
Among the five cell lines, 4.6% to 12.7% of EIs coin-
cided with transcriptional start sites (TSSs), which asso-
ciated with 60 to 409 genes across cell types. Compared
to random, the enrichment at TSS ranged from 2.7















Figure 2 (See legend on next page.)
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Figure 2 Euchromatin islands (EIs) in LOCKs overlap CTCF interacting regions and DNase hypersensitive sites (DHSs). H3K9me2 log
ratios of HAEC are shown on the top track. CTCF binding regions and DHSs of HUVEC are denoted as light blue and orange bars, respectively. EIs
are small regions with strong negative signals within the body of LOCKs. A) Shown is a 3 Mb long region (top) containing CHD11 genes
(zoomed-in view on the bottom), a member of the cadherin gene family. CFCF interacting regions and DHSs are highly depleted in the
H3K9me2 blocks (LOCKS), but overlap the EI located near the TSS of CDH11 gene. B) Additional examples of EIs near GP2 and PDILT genes.
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the spatial relationship between EI and CpG islands
(CGI). We found that 4.7% to 17% of EIs overlapped
with CGIs, with enrichment ranging from 0.6 to 2.1.
The randomization test suggested that EIs significantly
overlapped with CGI in differentiated cells, but not in
ES and iPS cells (Table 1).
To probe the chromatin features of EIs, we com-
pared locations of EIs in H1, HAEC and HPF with
public datasets of comparable cell lines [10,23]. Inter-
estingly, EIs highly coincide with regions interacting
with CCCTC-binding factor (CTCF), the major organ-
izer of higher-order chromatin in mammalian genomes
(Figure 2). Overall, up to 61.3% of EIs overlap with
CTCF binding regions, which are 8.2-fold enriched
compared with the random pattern (P < 10-3, Table 2).
Furthermore, up to 49% of EIs overlap with DNase
hypersensitive sites (DHSs), the hallmark of open chro-
matin, which is 6.5-fold enrichment compared with the
random (P < 10-3, Figure 2 and Table 2). We further
explored the overlaps of EIs with other histone
modifications, and found that EIs highly overlaps
with H3K4me3 (Enrichment up to 5.3) and H3K9ac
(Enrichment up to 3.3), but less enrich for H3K27me3
(Enrichments from 1.7 to 2.2) and H3K36me3 (Enrich-
ments from 0.7 to 2.1). The enrichments are similar
among the three cell types. In addition, we investigated
the enrichment by comparing EIs with random pattern
within LOCK regions, and got similar results and even
stronger enrichments for CTCF (up to 13.9 fold,
Table 2).
We then asked whether there is any association be-
tween EIs and DMRs. For this purpose, we compared
genomic locations of EIs with DMRs identified by
CHARM array [17,18]. We found that EIs are highly
enriched for DMRs distinguishing tissue types (T-DMRs).
For example, EIs near TSSs of nitric oxide synthase
1 (NOS1), xylosyltransferase I (XYLT1) and heparan
sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1) all
overlap T-DMRs (Figure 3). Overall, a large fraction of
EIs (39-62% across the five cell types) overlap with
T-DMRs, with enrichment from 2.1 to 2.9 folds relative
to random patterns (Table 3; p < 10-3).
We further tested the relationship between EIs and
DMRs associated with reprogramming (R-DMRs). Simi-
lar to T-DMRs, R-DMRs were more methylated in iPSC
cells compared to fibroblasts (Hyper R-DMRs) were alsosignificantly enriched in EIs of all the cell types, whose
enrichments ranging from 2.2 to 3.2 fold. However,
R-DMRs less methylated in iPSC cells (Hypo R-DMRs)
were highly enriched in EIs of differentiated cells (5.1 to
6.2 folds enrichment, P values all < 10-3), but much less
enriched in PSCs (1.2 to 3.1 folds of enrichment). Im-
portantly, EIs in HPF, the same cell type of parental cells
in reprogramming, are strongly enriched for hypomethy-
lated R-DMRs (enrichment = 6.1, P < 10-3), whereas
those in iPSCs did not significantly overlap with
hypomethylated R-DMRs (enrichment = 1.2, P = 0.33),
indicating a coordinated hypomethylation in these EIs
during reprogramming.
We then compared EI locations with colon cancer-
associated DMRs (C-DMRs) and observed an opposite
trend to that of R-DMRs. EIs in 4 out of 5 cell lines were
significantly enriched for C-DMRs more methylated in
colon cancers (hypermethylated C-DMRs), and the en-
richment ranged from 3.8 to 5.4 fold (Table 3). In con-
trast, all five cells types were not significantly enriched
for C-DMRs less methylated in cancers (hypomethylated
C-DMRs). These results were further confirmed by com-
paring EIs with an independent list of C-DMRs discov-
ered by whole genome bisulfite sequencing [20]. EIs of
all five cell lines significantly overlapped hypermethy-
lated C-DMRs (enrichment from 4.1 to 7.6 fold, P values
all < 10-3), whereas none of them were significantly
enriched for hypomethylated C-DMRs (Table 3). Inter-
estingly, almost all EIs (98%) that associated with hyper-
methylated C-DMRs also overlap CGIs. These data
suggest that EIs in normal cells may become hyper-
methylated in cancers.
To explore the biological role of EIs, we compared ex-
pression levels of genes associated with EIs, of genes
with LOCKs but not EIs, and of genes not overlapping
LOCKs (Figure 4A). It is clear that expressions of genes
overlapping EIs are significantly higher than those of
within LOCKs but not EIs (t-test, p < 2–16). To further
test whether EI associated genes are regulated by other
histone marks, we investigated the relationship between
H3K36me3/H3K27me3 and genes with EIs, with LOCKs
and without LOCKs (Figure 4B). In either category (with
or without K36me3/K27me3), genes at LOCK regions
always have the lowest expression and genes at non-
LOCK regions have the highest. However, genes with
EIs have expressions in the middle, and positively
(negatively) associated with H3K36me3 (H3K27me3),





% of EIs overlap
CGIs (En.b, Pc)





H1 1,060 4880 9.7 (1.3, 0.06) 7.9 (5.0, <10-3) 119
ADA-38 758 4401 4.7 (0.6, 0.99) 4.6 (2.7, <10-3) 60
HA 2,254 5029 14.2 (1.8, <10-3) 12.4 (7.8, <10-3) 338
HAEC 2,359 5867 13.6 (1.6, <10-3) 11.3 (5.4, <10-3) 373
HPF 2,465 5477 17 (2.1, <10-3) 12.7 (6.5, <10-3) 409
a 1 kb up and downstream of TSS overlapping EIs; b Enrichment compared to random patterns; c p values calculated by 1,000 permutations.
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these two marks.
Then we conducted Gene Ontology (GO) analysis with
genes whose TSSs are associated with EIs. EI-associated
genes in differentiated cells were strongly associated
with 1) biological processes such as system development,
cell adhesion and cell differentiation; 2) cellular com-
partments of plasma membrane and synapse, and
3) molecular function of ion binding and channel
activity (Table 4).
Finally, to test whether EIs are associated with specific
cellular functions, we compared the location of EIs
among the three differentiated cell lines. Based on our
current strategy to define EIs, ~50% of them are cell
type specific (Figure 5A). It should be noted that the de-
tection of EI is based on the definition of LOCKs as wellTable 2 Overlaps (%) of EIs with chromatin marksa
EIs overlap with Observed Random within LOCKs Fold e


















a EIs of HAEC, H1 and HPF were compared with chromatin marks of HUVEC, H1 and
bP values were calculated by 1000 permutations.
cEnrichment is calculated as the ratio of observed to random.as the amount of reduction of H3K9me2 levels within
LOCK bodies. Some tissue specific EIs may be due to
differential LOCKs or different amount of H3K9me2
reductions among cell types. Due to these reasons the
number of tissue specific EIs is likely an over-estimate.
New technology with higher resolution and dynamic
range, such as ChIP-seq, will help achieve better accur-
acy and specificity in tissue comparisons. Nevertheless,
we found that some tissue specific EIs are biologically
meaningful. For example, an EI is located near the
TSS of Down syndrome cell adhesion molecule gene
(DSCAM) in astrocytes (HA) but not the other two cell
types (Figure 5B). It was shown that Dscam diversity is
essential for neuronal circuit assembly [24], and genetic
variations of this gene were associated with Down syn-
drome and congenital heart disease (DSCHD) [25] andnrichedc P valueb Random at WG Fold enrichedc P valueb
13.9 <10-3 7.5 8.2 <10-3
4.8 <10-3 7.5 6.5 <10-3
3.4 <10-3 5.6 4.2 <10-3
1.4 <10-3 27.8 1.7 <10-3
1.4 <10-3 9.7 2.1 <10-3
2.9 <10-3 5.3 3.3 <10-3
5.2 <10-3 11.8 4.0 <10-3
5.1 <10-3 18.1 2.0 <10-3
7.4 <10-3 1.4 9.8 <10-3
2.0 <10-3 9.8 2.2 <10-3
0.7 1 15.2 0.7 1
2.4 <10-3 11.5 2.5 <10-3
7.2 <10-3 9.6 5.9 <10-3
2.6 <10-3 19.2 3.7 <10-3
3.8 <10-3 13.0 2.4 <10-3
1.6 <10-3 29.0 1.8 <10-3
1.4 <10-3 24.9 0.9 0.85
5.2 <10-3 6.2 2.1 <10-3






















Figure 3 (See legend on next page.)
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Figure 3 EIs are enriched for differential methylation regions (DMRs). The H3K9me2 signals of HAEC and HPF are compared with regions of
T-DMRs (pink bars). Regions of CHARM array are denoted by green bars. EIs (red dips) clearly overlap T-DMRs near the TSSs of NOS1 (A), XYLT1 (B)
and HS3HT1 (C).
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5’ end of myocardin (MYOCD) gene in HA and HPF but
HAEC (Figure 5C). Myocardin is a coactivator of serum
response factor which specifically expressed in cardiac
and smooth muscle cells [27], and promoter variation of
this gene was proposed as a biomarker of cardiac hyper-
trophy [28]. These data suggest that EIs may be import-
ant in regulating specific cellular functions.
Discussion
In summary, by examining the genome-wide distribu-
tion of H3K9me2 in human PSCs and differentiated
cells, we found a novel microstructure within hetero-
chromatin domains of thousands of small euchromatin
islands (EIs) located within large H3K9me2 blocks
(LOCKs). EIs are strongly associated with open chroma-
tin regions (DHSs), active chromatin marks (H3K4me3
and H3K9ac) and higher-order chromatin organizers
(CTCF). Furthermore, EIs are highly enriched for DMRs
associated with tissue specificity (T-DMRs), reprogram-
ming (R-DMRs) and cancers (C-DMRs). This associ-
ation is particularly strong for hypomethylated R-DMRs
and hypermethylated C-DMRs. Genes associated with
EIs are enriched for annotations of system development,
cellular differentiation and cell adhesion. These results
suggested that EIs may coordinate higher order chroma-
tin and mediate co-regulation of DNA methylation in
reprogramming and tumorigenesis. However, further
experimental work is needed to address the functional
relevance of EIs and their strong association with
CTCF and DMRs.
In this study, we compared H3K9me2 profiles with
publicly available epigenomic data generated from simi-
lar cell types. This strategy may lead to biased estimation




% En. p % En. p % En. p %
H1 53.4 2.8 <10-3 19.4 3.1 <10-3 5.8 3.1 0.02 11
ADA-38 39.1 2.1 <10-3 17.4 3.2 <10-3 2.2 1.2 0.33 6
HA 60.4 2.9 <10-3 19.3 3.1 <10-3 11 5.5 <10-3 16
HPF 59.5 2.8 <10-3 17.5 2.8 <10-3 12.8 6.1 <10-3 17
HAEC 62.3 2.9 <10-3 14.3 2.2 <10-3 11.7 5.6 <10-3 15
Notes: En. = Enrichment. Statistical significances were tested by 1000 permutationsbecause patterns of EIs may be different between the
two samples. Comparison of exactly matched cell lines
and cultures could assess the association between them
more accurately.
Note that a previous literature used the term “euchro-
matic islands” in a completely different context, simply
to describe chromatin regions with H3K4me3 and CpG
islands, essentially describing promoter regions of active
genes [4,29]. As that term was rarely used previously,
and to convey a completely different meaning, we do
not think there will be confusion with our newly defined
(and differently spelled) “euchromatin islands” or EIs,
namely H3K9me2 depleted regions/islands within an
ocean of heterochromatin (LOCKs), enriched for regula-
tory elements such as enhancers (DHSs) and insulators
(CTCF). Thus, EIs are novel units of the genomic “tool
box” which may be important in epigenetic regulation
as suggested by their strong association with DMRs
(Table 3).
Higher-order organization of the genome remains a
highly active area to be explored. Recent evidence indi-
cates the presence of spatial compartments of active and
repressive chromatin domains as general principles of
genome organization in mammalian cells [30,31], and
CTCF mediates intra- and inter-chromosomal interac-
tions by tethering chromatin regions binding CTCF [32].
It would be interesting to explore the possibility that eu-
chromatin islands act as “anchors” for the interactions
among heterochromatin domains or between hetero-
chromatic and enchromatic regions. Moreover, the rela-
tionships between EIs and heterochromatin formation,
and the biophysical features of EIs are interesting ques-
tions for future investigation.
Although evidence provided in this and other stud-
ies have indicated that large heterochromatin domainswith DMRs (%)
C-DMR Whole genome C-DMR
Hyper Hypo Hyper Hypo
En. p % En. p % En. p % En. p
.7 3.8 <10-3 4.9 1.4 0.24 5.6 5.2 <10-3 0.9 1 0.31
.5 2.2 0.05 6.5 2 0.08 4.1 4.1 <10-3 0.4 0.5 0.84
.7 5.4 <10-3 4.5 1.3 0.25 8.6 7.3 <10-3 1 1.1 0.34
.5 5.1 <10-3 5.7 1.5 0.09 9.4 7.6 <10-3 1.3 1.4 0.04
.7 4.5 <10-3 4.6 1.2 0.29 7 5.3 <10-3 1.1 1.1 0.27
.
BA
Figure 4 Expression of genes associated with EIs. We compared expression levels for genes with TSS at different regions. Expression values
are RPKM (read per kb per million reads) for lung fibroblast IMR90 [7]. A) boxplot of expression level of genes with TSS 1) overlapping EIs;
2) overlapping LOCKs but not EIs; and 3) not overlapping EIs. B) Relationship between H3K36me3/H3K27me3 and expression of EI associated genes.
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Table 4 Top 10 GO terms of genes associated with EIs
GO terms % of genes Fold en. FDR
Biological processes
nervous system development 12.6 2.2 9E-11
developmental process 25.5 1.6 4E-09
system development 20.5 1.7 4E-09
anatomical structure development 21.5 1.6 1E-08
multicellular organismal development 23.4 1.6 2E-08
cell adhesion 8.7 2.4 8E-08
biological adhesion 8.7 2.4 8E-08
cell differentiation 15.2 1.8 4E-07
cell development 8.0 2.4 4E-07
multicellular organismal process 31.1 1.4 4E-07
Cellular compartment
plasma membrane part 21.1 1.9 4E-14
plasma membrane 30.3 1.6 1E-12
membrane part 44.2 1.3 1E-09
integral to plasma membrane 12.6 2.1 3E-09
intrinsic to plasma membrane 12.7 2.1 5E-09
membrane 47.0 1.3 2E-08
intrinsic to membrane 37.3 1.4 2E-07
integral to membrane 35.9 1.4 1E-06
synapse 5.3 3.0 2E-06
extracellular region 16.7 1.7 6E-06
Molecular function
calcium ion binding 9.7 2.1 4E-06
gated channel activity 4.5 2.9 9E-05
molecular transducer activity 17.5 1.5 6E-04
signal transducer activity 17.5 1.5 6E-04
substrate specific channel activity 5.1 2.5 6E-04
ion channel activity 4.9 2.5 8E-04




cation channel activity 3.9 2.8 2E-03
ligand-gated channel activity 2.3 3.6 1E-02
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tumorigenesis [11-15], Lienert et al. indicated that gen-
ome coverage of H3K9me2 domains do not increase
globally during neuronal differentiation of mouse ES
cells [33]. First of all, lineage specificity of differentiated
cells may explain the conflicts. As reported in our earl-
ier work [11] the amount of LOCKs detected from
brain and ES cells are comparable (9.8% vs. 4%),
whereas the amount is very high in liver (45.6%). The
Lienert study used in vitro differentiated neurons as dif-
ferentiated cells which is more similar to brain. Further-
more, the inconsistence may be due to sensitivities ofdifferent statistical methods for finding large domains,
heterogenenity of stem cells, and so on. Notably, exten-
sive deduction of LOCKs during EMT suggested that
quantitative differences of these large domains may be
functionally important [13]. Nevertheless, further stud-
ies on homogenous stem cell populations may be help-
ful to address these debates. Whatever it holds,
functionally investigations of these large domains should
provide important insight toward how higher-order
chromatin affects normal development and disease.
Conclusions
In conclusion, we have explored the microstructure of
LOCKS and indentified thousands of euchromatin
islands (EIs), which may be served as a finer layer of epi-
genomic architecture within large heterochromatin
domains. The strong association of EIs with CTCF sites,
DNAse hypersensitivies sites, and DMRs suggests that
EIs play an important role in normal epigenomic archi-
tecture and its disruption in disease.
Methods
Cell culture
Human H1 ESCs and ADA-38 iPSCs were cultured as
described [34]. Primary Human Pulmonary Fibroblasts
(HPF), Human Aortic Endothelial Cells (HAEC) and
Human Astrocytes (HA) were purchased from ScienCell
Research Laboratories (San Diego, CA), and cultured as
recommended by ScienCell.
ChIP-chip
ChIP-chip experiments were performed as described
[11], using a commercial monoclonal antibody (Abcam,
ab1220), which specifically recognizes H3K9me2 but not
other modifications [35]. The passage numbers for cells
used for ChIP analysis were P46 for H1, P59 for ADA-
38 and P2 for primary cells from ScienCell. We first
mapped whole genome distribution of H3K9me2 using
“Mouse ChIP-chip 2.1M Economy Whole-Genome Til-
ing arrays (4 arrays per set) from NimbleGen”, with
203 bp of median probe spacing. Then we repeated the
microarray experiments on one of the Mouse ChIP-chip
2.1 M Whole-Genome Tiling sets, whose median probe
spacing is 100 bp. The replicate array covers 10% of the
genome, including part of chromosome 6 (111,920,
005-170,893,515), whole chromosome 7 and part of chro-
mosome 8 (521–74,730,105). For the replicate experi-
ments, cell cultures, ChIP sample preparation, labeling
and hybridization were performed independently.
ChiP-chip data analysis
Data were first normalized by partial quantile
normalization, then LOCKs were detected based on the

















Figure 5 Cell type specific EIs. A) The Venn diagram shows overlaps of EIs among three differentiated cell lines (HA, HAEC and HPF). B-C)
Shown are examples of EIs which differ among cell types. The annotation of tracks is the same as in Figures 2 and 3. An EI is found near the 5’
end of the myocardin gene (MYOCD) in HA and HPF but not in HAEC. An EI is found in the TSS of the Down syndrome cell adhesion molecule
gene (DSCAM) specifically in HA but not in other two cell types (C).
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islands (EIs) are defined as short regions within LOCK
body that have low H3K9me2 methylation levels. To de-
tect such regions we designed the following smoothing
based approach. The log2 ratios for probes within
LOCKs were first smoothed using 5000 bp window. The
relatively short smoothing window is used to capture the
signal variations in small regions. Genomic regions with
smoothed value less than 1% of all the smoothed values
were defined as EIs. It is required that EIs are at least
1000 bps long and contain at least 10 probes. EIs less
than 1000 bps apart will be merged into one. It is also
required that the EIs are at least 20000 bps away from
the LOCK boundaries. This is because the log2 ratios
are smaller at LOCK boundaries. Such requirement pre-
vents mistakenly taking LOCK boundaries as EIs. A flow
diagram showing the algorithm for detecting EIs was
provided in Additional file 8: Figure S6. Microarray data
have been submitted to GEO database (accession num-
bers: GSE37335).To compute the enrichment of EI overlapping other
genomic features (CTCF, DHS, etc.), we first calculated
the percent of EIs overlapping the feature. Then a set
of genomic regions was randomly sampled. The num-
ber and lengths of the random regions match the EI
list. The random regions were then compared with the
feature to obtain a percentage of overlapping. Such
process was repeated 1000 times. The percentages
obtained from the process form the null distribution
for percentage of overlapping. The p-values and
enrichments were computed based on the null distri-
bution. The p-values were then corrected for multiple
testing using Bonferroni correction. Publicly available
datasets used for analysis were listed in Additional
file 9: Table S3.
Quantitative PCR (qPCR)
Experiments of qPCR were conducted as described [11].
Primer sequences are provided in Additional file 10:
Table S4.
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GO analysis was performed using DAVID tools as
described [36], using the list of genes overlapping EIs of
the three differentiated cell lines (HA, HAEC and HPF).
Additional files
Additional file 1: Table S1. Description: Genome coverage and average
size of LOCKs in human PSCs and differentiated cells.
Additional file 2: Figure S1(A-D). Description: qRCR validation of
H3K9me2 ChIP-chip data on 23 loci. Upper panels show log2 (ChIP/Input)
ratios of microarrays and green bars denote regions selected for qPCR
validation; lower panels present qPCR enrichments of ChIP over input in
the selected regions.
Additional file 3: Figure S2. Description: LOCKs overlap partial
methylation domains (PMDs). (A) One representative region (on
chromosome 17) where LOCKs and PMDs overlap, green and orange
bars show locations of LOCK (green) and PMD (orange), and
hypomethylation blocks (purple), respectively; (B) H3K9me2 density in
and out of PMDs. X-axis is the probe log2 ratios between ChIP and
control samples. Y-axis is the the probability density.
Additional file 4: Table S2. Description: Coordinates of EIs (HG18).
Additional file 5: Figure S3. Description: Average H3K9me2 densities in
EIs and their adjacent regions.
Additional file 6: Figure S4. Description: H3K9me2 ChIP-chip
experiments in whole genome (WG) and replicate (rep) arrays.
Additional file 7: Figure S5. Description: Nucleosome density in EIs
and adjacent regions. We compared common EIs of HA, HAEC and HPF
with nucleosome maps of GM12878 (Supplementary Table S3), to
overcome potential lineage specificity among those cell types.
Additional file 8: Figure S6. Description: Flow diagram of EI
detection.
Additional file 9: Table S3. Description: Public datasets used for
analysis.
Additional file 10: Table S4. Description: qPCR primer sequences.
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